Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
ContributorsDe Bleser, Elise; Jereczek-Fossa, Barbara Alicja; Pasquier, David; Zilli, Thomas; Van As, Nicholas; Siva, Shankar; Fodor, Andrei; Dirix, Piet; Gomez-Iturriaga, Alfonso; Trippa, Fabio; Detti, Beatrice; Ingrosso, Gianluca; Triggiani, Luca; Bruni, Alessio; Alongi, Filippo; Reynders, Dries; De Meerleer, Gert; Surgo, Alessia; Loukili, Kaoutar; Miralbell, Raymond; Silva, Pedro; Chander, Sarat; Di Muzio, Nadia Gisella; Maranzano, Ernesto; Francolini, Giulio; Lancia, Andrea; Tree, Alison; Deantoni, Chiara Lucrezia; Ponti, Elisabetta; Marvaso, Giulia; Goetghebeur, Els; Ost, Piet
Published inEuropean Urology, vol. 76, no. 6, p. 732-739
Publication date2019
Keywords
- Elective nodal radiotherapy
- Metastasis-directed therapy
- Oligometastasis
- Oligorecurrence
- Prostatic neoplasms
- Radiotherapy
- Recurrence
- Stereotactic ablative body radiotherapy
- Stereotactic body radiotherapy
Affiliation entities
Citation (ISO format)
DE BLESER, Elise et al. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. In: European Urology, 2019, vol. 76, n° 6, p. 732–739. doi: 10.1016/j.eururo.2019.07.009
Main files (1)
Article (Published version)
Identifiers
- PID : unige:136221
- DOI : 10.1016/j.eururo.2019.07.009
- PMID : 31331782
Journal ISSN0302-2838
